Home » Newsletters » BioWorld Science

BioWorld Science

March 19, 2021

View Archived Issues

CSPC cleared to begin clinical trials in China with SYHX-1901 for rheumatoid arthritis and SLE

MatriSys licenses MSB-3163 for acne from UCSD

Preliminary phase I/II results for SGT-001 in DMD support its further investigation

First patient enrolled in phase IIa clinical study of ARQ-252 as potential treatment for vitiligo

Exelixis collaborates with Merck KGaA and Pfizer to evaluate XL-092 plus avelumab in UC

GSK and ViiV Healthcare patent compounds for HIV infection

Kainos Medicine synthesizes new CD73 inhibitors

Kukje Pharma presents new mPGES-1 inhibitors

Peptomyc obtains approval for first-in-human phase I/II study of Omomyc

AlzeCure Pharma AB describes new compounds for AD

Dual labeling study finds no evidence of pancreatic beta cell neogenesis

Allogene Therapeutics patents CART cells for cancer

Characterization of a new mouse model of Parkinson's disease

China's NMPA approves emergency use of recombinant protein subunit vaccine against COVID-19

Phase II interim analysis data presented for apitegromab in patients with SMA

Idera reports ORR endpoint data from phase III trial of tilsotolimod for advanced melanoma

Sarepta Therapeutics presents results for SRP-9001 gene therapy in nonhuman primates

Incyte reports phase III results with ruxolitinib for COVID-19-associated ARDS

FDA approves Arcalyst for recurrent pericarditis

PGT-121 is effective without effector functions

Phase II study of AMY-101 for periodontal inflammation and gingivitis meets endpoints

New phase Ib/II trial evaluates CM-24 in advanced cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...